John Ling - Concepedia

Author

John Ling

Gilead Sciences (United States)

Also Known As

J R Ling, J. Ling, J. R. LING, J. R. Ling, J.R. Ling, JOHN R. LING, Jingyu Ling, John Ling, John R. Ling, Sandra Lewis

Publications

1.9K

Citations

H-Index

Concepts

All Affiliations

Gilead Sciences (United States)Aberystwyth University University of Wales University of Miyazaki VIR Biotechnology (United States)

About

John Ling is an author at Gilead Sciences (United States) specializing in medicine, biochemistry, and microbiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	16	887
2	Engineering	3	3	43
3	Health Sciences	3	3	102
4	Education	2	2	162
5	Arts	1	1	46

John Ling

Publications

1.7K

Citations

H-Index

Page 1

	Year	Citations
Clinical targeting of HIV capsid protein with a long-acting small molecule John O. Link, Martin S. Rhee, Winston C. Tse, Nature Natural SciencesHuman RetrovirusImmunologyAntiviral TherapyMolecular Biology	2020	392
Safety, Tolerability, and Pharmacokinetics of Remdesivir, An Antiviral for Treatment of COVID‐19, in Healthy Subjects Rita Humeniuk, Anita Mathias, Huyen Cao, Clinical and Translational Science	2020	261
The simultaneous use of ribonucleic acid,<sup>35</sup>S, 2,6-diaminopimelic acid and 2-aminoethylphosphonic acid as markers of microbial nitrogen entering the duodenum of sheep John Ling, P. J. Buttery British Journal Of Nutrition NutritionAgricultural EconomicsEducationVeterinary MicrobiologyDigestive Tract	1978	145
Trospium chloride has no effect on memory testing and is assay undetectable in the central nervous system of older patients with overactive bladder David Staskin, Gary G. Kay, Cara Tannenbaum, International Journal of Clinical Practice	2010	133
Cytochrome P450 3A Induction Predicts P‐glycoprotein Induction; Part 1: Establishing Induction Relationships Using Ascending Dose Rifampin Justin D. Lutz, Brian J. Kirby, Lu Wang, Clinical Pharmacology & Therapeutics	2018	81
Cytochrome P450 3A Induction Predicts P‐glycoprotein Induction; Part 2: Prediction of Decreased Substrate Exposure After Rifabutin or Carbamazepine Justin D. Lutz, Brian J. Kirby, Lu Wang, Clinical Pharmacology & Therapeutics Pxr AgonistPharmacotherapyExperimental PharmacologyPhysiologically-based Pharmacokinetic ModelingPharmacodynamic Modeling	2018	74
The <i>in vitro</i> uptake and metabolism of peptides and amino acids by five species of rumen bacteria John Ling, Ian Armstead Journal of Applied Bacteriology Amino AcidsBovis Jb1BacteriologyMicrobial PhysiologyFeed Utilization	1995	53
Pharmacokinetics and Disposition of Momelotinib Revealed a Disproportionate Human Metabolite—Resolution for Clinical Development Jim Zheng, Xin Yan, Jingyu Zhang, Drug Metabolism and Disposition	2018	50
Preclinical Pharmacokinetics and First-in-Human Pharmacokinetics, Safety, and Tolerability of Velpatasvir, a Pangenotypic Hepatitis C Virus NS5A Inhibitor, in Healthy Subjects Erik Mogalian, Polina German, Brian P. Kearney, Antimicrobial Agents and Chemotherapy	2017	48
Quality of life outcomes after ventilating tube insertion for otitis media in an Australian population Yan Yee Julianna Chow, David Wabnitz, John Ling International Journal of Pediatric Otorhinolaryngology Life OutcomesPediatric OtolaryngologyPatient SafetyOtolaryngologyOtorhinolaryngology	2007	46

Page 1